LSF News & Events

Laird Superfood completed the acquisition of Terrasoul Superfoods for $48M in cash, subject to customary purchase price adjustments, with an additional earnout of up to $5M payable in cash if certain performance-based milestones are achieved. For the fiscal year ended December 31, 2025, Terrasoul generated unaudited Net Sales of approximately $65.8M The Terrasoul Acquisition was funded through a concurrent private placement of $60M of Series A Convertible Preferred Stock to affiliates of Nexus Capital Management that was previously committed under Laird Superfood's investment agreement with Nexus, which was approved by the Company's stockholders on March 12, 2026 in connection with the Navitas Organics transaction for future acquisitions on substantially the same terms. Following the incremental investment, Nexus will own approximately 71.7% of the issued and outstanding shares of Laird Superfood on a fully diluted, as-converted basis.

Stock futures are modestly lower ahead of the open, indicating a weaker start. The move follows another sharp decline in the prior session, where the S&P 500 fell more than 1% and the Nasdaq dropped over 2%, moving into correction territory.The primary driver remains energy. Oil prices are rising again, with Brent crude trading above $110 per barrel. Although prices are on track for a slight weekly decline, they remain significantly elevated due to ongoing supply disruptions tied to the Iran conflict.That persistence in elevated oil prices is continuing to feed into broader market conditions. Treasury yields are climbing, with the 10-year approaching the mid-4% range, and rate expectations have shifted meaningfully. Markets that previously anticipated rate cuts are now pricing in the possibility of further tightening, reflecting concern that the energy shock could keep inflation elevated.In pre-market trading, S&P 500 futures fell 0.45%, Nasdaq futures fell 0.67% and Dow futures fell 0.39%.Check out this morning's top movers from around Wall Street, compiled by The Fly.HIGHER -AstraZenecaup 4% after announcing tozorakimab met the primary endpoint in OBERON and TITANIA trialsUP AFTER EARNINGS -Newsmaxup 12%Arganup 10%Legenceup 9%BioXcel Therapeuticsup 3%DOWN AFTER EARNINGS -Humacytedown 7%P3 Health Partnersdown 6%Autolus Therapeuticsdown 4%Laird Superfooddown 4%LOWER -Two Harborsdown 1% after entering into a definitive merger agreement pursuant to which CrossCountry will acquire all of the outstanding shares of Two Harbors common stock for $10.80 per share in cash

Check out this evening's top movers from around Wall Street, compiled by The Fly.Hopes for a near-term resolution to U.S.-Iran standoff continue to fade with more saber-rattling comments out of both sides, denting equity markets that are already reeling from internal challenges while goosing up energy prices.  Thursday's market action was decidedly negative as Nasdaq Composite index also officially closed in "correction" territory - down by over 10% from its February highs.  Communication Services sector was especially hard-hit as the sector's top two stocks - Alphabetand Meta- fell 3% and 8% respectively in the wake of an adverse court ruling regarding social media addiction.  Those stocks are now down 10% and 17% year-to-date, while the State Street Communication Services ETF, of which they are the top two holdings, is down 10% from the highs.In the opening hour of the evening session, S&P 500 and Nasdaq 100 futures contracts are up 0.3% following Truth Social post by Trump that Iran would be granted another extension until its energy infrastructure assets are bombed, though that bounce is fairly shallow after the 1.7% and 2.4% declines in the respective indices on Thursday.  WTI Crude Oil trades just above $93 per barrel - off the Thursday highs above $95.50 but also well off the lows near $90 seen after the Trump post, with traders consistently fading the president's attempts to signal a path toward de-escalation.HIGHER AFTER EARNINGS -Arganup 9.5%Newsmaxup 5.5%ALSO HIGHER -Unity Softwareup 14.4% after raising Q1 revenue guidanceSIGA Technologiesup 9.9% after declaring special dividendDOWN AFTER EARNINGS -Laird Superfooddown 11.0%P3 Health Partnersdown 6.8%ALSO LOWER -Lithium Argentinadown 11.4% after block saleZenas BioPharmadown 9.8% after equity offering